Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Marc Kahn who wrote (176)	5/5/1998 11:47:00 PM
From: GREG FINLEY	Respond to of 534

Thanks Marc, I would call this board the realistic, technical board. I still like interaction on the other, but some of the latest contributions have been less than inspiring. Good to be here too. Earnings report due 5/12...it will probably be late by a couple of days. That has been the norm the past few times. My friend in Oregon and I are VERY interested in seeing how they will handle the stock swap with ELAN. Remember, the deal had a negative affect on their last report...to the tune of -$.51. Even though it is just an accounting procedure, they have to show the +$12,000,000 somewhere! It should be very interesting. Also, there are some additional states in the pipeline interested in using the Biojector 2000. And perhaps...perhaps we will get some kind of a "message" reference the early test results from the glucose monitor. I'm probably being too hopeful. The supply is there...but holding at $2. I guess there are alot of smaller investors who bought at 3/4 to 1 1/4, who aren't willing to wait for the ride to get good! Let them shake out. I really think this is just the beginning, and that with ANY kind of positive news coupled with a modest earnings (unearnings) report,...well, $4 to $5 short term is probably conservative considering the huge market potential. Thanks again Marc, GF